Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pleural Effusion | 1 | 2024 | 60 | 0.800 |
Why?
|
| Serratia marcescens | 4 | 2016 | 18 | 0.770 |
Why?
|
| Caenorhabditis elegans | 5 | 2016 | 337 | 0.680 |
Why?
|
| Self-Fertilization | 4 | 2016 | 5 | 0.660 |
Why?
|
| Office Visits | 2 | 2016 | 90 | 0.570 |
Why?
|
| Hand | 2 | 2016 | 161 | 0.530 |
Why?
|
| Cancer Pain | 1 | 2017 | 37 | 0.480 |
Why?
|
| Analgesics | 1 | 2017 | 231 | 0.430 |
Why?
|
| Cannabinoids | 1 | 2017 | 182 | 0.430 |
Why?
|
| Host-Pathogen Interactions | 5 | 2016 | 371 | 0.420 |
Why?
|
| Perception | 1 | 2015 | 377 | 0.380 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 706 | 0.340 |
Why?
|
| Genetic Variation | 1 | 2016 | 986 | 0.330 |
Why?
|
| Biological Evolution | 4 | 2016 | 489 | 0.300 |
Why?
|
| Mental Disorders | 1 | 2017 | 1173 | 0.260 |
Why?
|
| Ventricular Pressure | 1 | 2024 | 52 | 0.210 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 2464 | 0.200 |
Why?
|
| Metagenomics | 1 | 2024 | 182 | 0.190 |
Why?
|
| Sputum | 1 | 2024 | 308 | 0.190 |
Why?
|
| Selection, Genetic | 2 | 2016 | 256 | 0.180 |
Why?
|
| Reproduction | 2 | 2014 | 207 | 0.170 |
Why?
|
| Ventricular Function, Left | 1 | 2024 | 541 | 0.160 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 588 | 0.160 |
Why?
|
| Genetic Fitness | 2 | 2016 | 59 | 0.130 |
Why?
|
| Serratia | 1 | 2016 | 3 | 0.120 |
Why?
|
| Microbiota | 1 | 2024 | 781 | 0.120 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2016 | 4 | 0.120 |
Why?
|
| Inbreeding | 1 | 2016 | 20 | 0.120 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 124 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 268 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2015 | 134 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2024 | 1162 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 697 | 0.100 |
Why?
|
| Health Literacy | 1 | 2016 | 184 | 0.100 |
Why?
|
| Orthopedics | 1 | 2016 | 169 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 517 | 0.090 |
Why?
|
| Sex | 1 | 2011 | 4 | 0.090 |
Why?
|
| Heart Failure | 1 | 2024 | 2331 | 0.080 |
Why?
|
| Logistic Models | 1 | 2015 | 2119 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 572 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 7186 | 0.070 |
Why?
|
| Middle Aged | 3 | 2017 | 36021 | 0.060 |
Why?
|
| Humans | 5 | 2024 | 145305 | 0.050 |
Why?
|
| Freezing | 1 | 2024 | 86 | 0.050 |
Why?
|
| Cryopreservation | 1 | 2024 | 110 | 0.050 |
Why?
|
| Respiratory System | 1 | 2024 | 149 | 0.050 |
Why?
|
| Hermaphroditic Organisms | 2 | 2014 | 2 | 0.050 |
Why?
|
| Female | 5 | 2024 | 78605 | 0.050 |
Why?
|
| Animals | 5 | 2016 | 38177 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2024 | 636 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2017 | 11731 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 824 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 550 | 0.040 |
Why?
|
| Aged | 2 | 2016 | 26001 | 0.040 |
Why?
|
| Bacteria | 1 | 2024 | 891 | 0.030 |
Why?
|
| Male | 4 | 2024 | 72628 | 0.030 |
Why?
|
| Hybridization, Genetic | 1 | 2016 | 75 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 98 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 210 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2011 | 52 | 0.020 |
Why?
|
| Extinction, Biological | 1 | 2011 | 38 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 392 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 40627 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 4104 | 0.010 |
Why?
|